The RECIPIENT of BIOLOGICAL RESOURCE must obtain a prior written consent on use of it from the DEPOSITOR/DEVELOPER. human alpha 1-antitrypsin promoter, human immunoglobulin heavy chain genomic DNA, Simian virus 40 Large T antigen nuclear localization signal (NLS), phage P1 Cre recombinase, Simian virus 40 poly A signal RBRC02157 Cre/loxP system Kazunari K. YOKOYAMA C57BL/6J-Tg(AAT-cre)50Rbrc C57BL/6J-Tg(AAT-cre)50Rbrc TG06-08#50 横山　和尚 B (1-3 months) 独立行政法人理化学研究所 B（1〜3か月） Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> RIKEN <a href='https://brc.riken.jp/mus/pcr02157'>Genotyping protocol -PCR-</a> 条件を付加する。<br>寄託者（開発者）の承諾を得る。 true